Revelation Biosciences, Inc.
REVB
$3.27
-$0.13-3.82%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,873.22% | -781.72% | -560.43% | 98.89% | 106.49% |
| Total Depreciation and Amortization | 7.14% | 3.57% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.08% | 99.00% | 93.42% | -2,684.82% | -2,104.13% |
| Change in Net Operating Assets | -212.37% | 1,253.80% | 137.02% | 234.37% | 1,096.62% |
| Cash from Operations | -166.03% | -44.68% | -7.34% | 35.06% | 52.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -34.71% | -70.69% | -70.69% | 19.73% | 19.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | 100.00% | 100.00% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -34.71% | -70.69% | -70.69% | -7.72% | -7.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.57% | -129.74% | -129.96% | 69.39% | 278.98% |
